Mostrar el registro sencillo del documento

The Clinical Impact of Thoracic Endovascular Aortic Repair in the Management of Thoracic Aortic Diseases

dc.creatorMolano, Fernando
dc.creatorRey Chaves, Carlos Eduardo
dc.creatorConde Monroy, Danny
dc.creatorGirón, Felipe
dc.creatorNúñez-Rocha, Ricardo E.
dc.creatorAyala, Daniela
dc.creatorGonzález, Juliana
dc.creatorCortés, Felipe
dc.creatorCortés, Diana
dc.creatorFajardo, Ernesto
dc.creatorBarón, Vladimir
dc.date.accessioned2023-01-17T21:28:40Z
dc.date.available2023-01-17T21:28:40Z
dc.date.created2023-01-07
dc.identifier.issn1526-6028spa
dc.identifier.urihttp://repositorio.mederi.com.co/handle/123456789/736
dc.descriptionPurpose: Thoracic endovascular aortic repair (TEVAR) has been described to be superior to an open surgical approach, and previous studies have found superiority in TEVAR by reducing overall morbidity and mortality rates. This study aimed to describe the outcomes of TEVAR for patients with thoracic aortic disease at a high complexity. Materials and Methods: Descriptive study, developed by a retrospective review of a prospectively collected database. Patients aged above 18 years who underwent TEVAR between 2012 and 2022 were included. Patient demographics, perioperative data, surgical outcomes, morbidity, and mortality were described. Statistical and multivariate analyses were made. Statistical significance was reached when p values were <0.05. Results: A total of 66 patients were included. Male patients were 60.61% and the mean age was 69.24 years. Associated aortic diseases were aneurysms (68.18%), ulcer-related (4.55%), intramural-related hematoma (7.58%), trauma-related pathology (1.52%), and aortic dissection (30.30%). The mean hospital stay was 18.10 days, and intensive care unit was required for 98.48%. At 30 days, the mortality rate was 10.61% and the reintervention rate was 21.21%. Increased intraoperative blood loss (p=0.001) and male sex (p=0.04) showed statistical relationship with mortality. Underweight patients have 6.7 and 11.4 times more risk of complications and endoleak compared with higher body mass index values (p=0.04, 95% confidence interval [CI]=0.82–7.21) and (p=0.02, 95% CI=1.31–12.57), respectively. Conclusion: Thoracic endovascular aortic repair seems to be a feasible option for patients with thoracic aortic pathologies, with adequate rates of mortality and morbidity. Underweight patients seem to have an increased risk of overall morbidity and increased risk for endoleak. Further prospective studies are needed to prove our results. Clinical Impact Obesity and BMI are widely studied in the surgical literature. According to our study, there is a paradox regarding the outcomes of patients treated with TEVAR in terms of postoperative complications and mortality related to the body mass index. And shouldn’t be considered as a high-risk feature in terms of postoperative morbidity and mortality inthis procedure.spa
dc.format.mimetypeapplication/pdfspa
dc.relation.urihttps://journals.sagepub.com/doi/10.1177/15266028221148381spa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleThe Clinical Impact of Thoracic Endovascular Aortic Repair in the Management of Thoracic Aortic Diseasesspa
dc.subject.keywordTEVARspa
dc.subject.keywordaortic pathologiesspa
dc.subject.keywordendoleakspa
dc.subject.keywordmorbidityspa
dc.subject.keywordmortalityspa
dc.subject.keywordBMIspa
dc.rights.accessRightsopenAccessspa
dc.type.hasVersionacceptedVersionspa


Archivos en el documento

ArchivosTamañoFormatoVer

No hay archivos asociados a este documento.

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento

Atribución-NoComercial-SinDerivadas 2.5 ColombiaExcepto si se señala otra cosa, la licencia del documento se describe como Atribución-NoComercial-SinDerivadas 2.5 Colombia